Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Arcellx Inc (ACLX)
Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,618,080
  • Shares Outstanding, K 48,000
  • Annual Sales, $ 0 K
  • Annual Income, $ -188,680 K
  • 60-Month Beta -0.34
  • Price/Sales 79.63
  • Price/Cash Flow N/A
  • Price/Book 5.24
Trade ACLX with:

Options Overview Details

View History
  • Implied Volatility 81.52% ( +14.98%)
  • Historical Volatility 44.24%
  • IV Percentile 14%
  • IV Rank 22.39%
  • IV High 133.44% on 10/14/22
  • IV Low 66.54% on 06/22/23
  • Put/Call Vol Ratio 7.13
  • Today's Volume 65
  • Volume Avg (30-Day) 43
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 1,182
  • Open Int (30-Day) 1,916

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 0.16
  • Number of Estimates 5
  • High Estimate 3.52
  • Low Estimate -1.00
  • Prior Year -0.88
  • Growth Rate Est. (year over year) +118.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.06 +3.81%
on 06/20/23
45.77 -27.29%
on 06/01/23
-10.13 (-23.34%)
since 05/23/23
3-Month
27.28 +21.99%
on 04/05/23
48.92 -31.96%
on 05/11/23
+4.99 (+17.64%)
since 03/23/23
52-Week
15.63 +112.92%
on 08/29/22
48.92 -31.96%
on 05/11/23
+16.47 (+97.98%)
since 06/23/22

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 33.28 (-1.28%)
Stocks End Moderately Lower Ahead of Powell’s Testimony to Congress

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.72%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

$SPX : 4,348.33 (-0.77%)
SPY : 433.21 (-0.76%)
$DOWI : 33,727.43 (-0.65%)
DIA : 337.16 (-0.64%)
$IUXX : 14,891.48 (-1.00%)
QQQ : 362.54 (-0.99%)
HAL : 30.89 (-1.22%)
DVN : 47.15 (-1.13%)
PSX : 90.86 (+0.06%)
APA : 32.58 (-1.90%)
CVX : 151.35 (-0.85%)
COP : 100.46 (-0.96%)
Markets Today: Stocks Slip on China Economic Concerns and Higher Bond Yields

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.33%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.28%. U.S. stock index futures this morning are moderately...

ESU23 : 4,389.00s (-0.79%)
NQU23 : 15,058.25s (-1.03%)
NKE : 109.52 (-0.85%)
PDD : 69.80 (-4.24%)
JD : 34.87 (-4.70%)
BABA : 84.92 (-2.27%)
NTES : 93.07 (-1.49%)
SOFI : 8.28 (-2.47%)
AMAT : 136.07 (-2.05%)
ACLX : 33.28 (-1.28%)
WBD : 11.79 (-2.48%)
DICE : 46.70 (+0.19%)
Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 33.28 (-1.28%)
Arcellx, Inc. (ACLX) Reports Q1 Loss, Misses Revenue Estimates

Arcellx, Inc. (ACLX) delivered earnings and revenue surprises of -123.02% and 86.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ACLX : 33.28 (-1.28%)
MIRO : 2.0300 (+22.29%)
Arcellx Provides First Quarter Financial Results

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 33.28 (-1.28%)
Zacks.com featured highlights Arcellx, Harrow Health, PROG, Chipotle Mexican Grill and Meta

Arcellx, Harrow Health, PROG, Chipotle Mexican Grill and Meta have been highlighted in this Screen of The Week article.

CMG : 2,043.68 (-0.33%)
HROW : 18.52 (unch)
PRG : 31.76 (-1.70%)
META : 288.73 (+1.35%)
ACLX : 33.28 (-1.28%)
5 Stocks With Recent Price Strength That Still Have Upside

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are META, CMG, ACLX, HROW and PRG.

CMG : 2,043.68 (-0.33%)
HROW : 18.52 (unch)
PRG : 31.76 (-1.70%)
META : 288.73 (+1.35%)
ACLX : 33.28 (-1.28%)
Arcellx, Inc. (ACLX) is a Great Momentum Stock: Should You Buy?

Does Arcellx, Inc. (ACLX) have what it takes to be a top stock pick for momentum investors? Let's find out.

ACLX : 33.28 (-1.28%)
Arcellx, Inc. (ACLX) Upgraded to Strong Buy: Here's What You Should Know

Arcellx, Inc. (ACLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ACLX : 33.28 (-1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.

See More

Key Turning Points

3rd Resistance Point 35.52
2nd Resistance Point 34.76
1st Resistance Point 34.02
Last Price 33.28
1st Support Level 32.51
2nd Support Level 31.75
3rd Support Level 31.01

See More

52-Week High 48.92
Fibonacci 61.8% 36.20
Last Price 33.28
Fibonacci 50% 32.27
Fibonacci 38.2% 28.34
52-Week Low 15.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar